Full name
CHEMENCE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.75.Z - Wholesale trade
20.52.Z - Manufacture of chemicals and chemical products
21.2 - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.5 - Production of medical devices, instruments, and products, including dental products
46.46 - Wholesale trade of pharmaceutical and medical products
46.75 - Wholesale trade
46.90 - Non-specialized wholesale trade
70.22.Z - Head office activities and management consultancy
72.11 - Scientific research and development activities
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0,3 | 0,2 | -45,9 |
Gross profit (loss) | 0,2 | 0,3 | 0,3 | -5,6 |
EBITDA | 0,2 | 0,3 | 0,2 | -46,1 |
Short time liabilities | 0,1 | 1 | 0,8 | -22,6 |
Other operating costs | 0 | 0 | 0 | 22,6 |
Equity capital | 0,3 | 0,5 | 0,7 | 44,7 |
Operating profit (EBIT) | 0,2 | 0,3 | 0,2 | -46,1 |
Assets | 0,3 | 1,6 | 1,6 | -0,4 |
Net profit (loss) | 0,2 | 0,2 | 0,2 | -6,2 |
Cash | 0,1 | 0,1 | 0,1 | -27,9 |
Liabilities and provisions for liabilities | 0,1 | 1 | 0,8 | -22,6 |
Net income from sale | 1,6 | 3,5 | 6 | 71,7 |
Working assets | 0,3 | 1,6 | 1,6 | -0,4 |
Other income costs | 0 | 0 | 0 | 20 200 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 55,9 | 47,7 | 30,9 | -16,8 |
Equity capital to total assets | 77,5 | 33,1 | 48 | 14,9 |
Gross profit margin | 10,6 | 7,8 | 4,3 | -3,5 |
EBITDA Margin | 9,9 | 9,6 | 3 | -6,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 109 | 49 | -60 |
Current financial liquidity indicator | 4.451202869415283 | 1.4943174123764038 | 1.92451012134552 | 0,4 |
Net dept to EBITDA | -0.5201433300971985 | -0.23777888715267181 | -0.3181367814540863 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane